CPI FIM SA (LUX:ORCL)
Luxembourg · Delayed Price · Currency is EUR 0.9600
0.00 (0.00%)
At close: Aug 8, 2025
Inozyme Pharma Market Cap
CPI FIM has a market cap or net worth of €1.26 billion as of August 8, 2025. Its market cap has increased by 100.84% in one year.
Market Cap
1.26B
Enterprise Value
5.54B
Revenue
167.35M
Ranking
n/a
PE Ratio
11.93
Stock Price
$0.96
Market Cap Chart
Since October 2, 2015, CPI FIM's market cap has increased from 72.34M to 1.26B, an increase of 1,644.52%. That is a compound annual growth rate of 33.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 1.26B | 14.29% |
| Dec 31, 2024 | 1.10B | 86.67% |
| Dec 29, 2023 | 591.53M | 15.63% |
| Dec 28, 2022 | 511.56M | -17.55% |
| Dec 30, 2021 | 620.45M | 81.54% |
| Dec 30, 2020 | 341.77M | -7.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reinet Investments S.C.A. | 4.54B |
| Luxempart | 1.36B |
| Socfinasia | 474.18M |
| Socfinaf | 338.90M |
| GP Investments | 87.72M |
| Velcan Holdings | 84.51M |